1. Home
  2. ADD vs APM Comparison

ADD vs APM Comparison

Compare ADD & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADD
  • APM
  • Stock Information
  • Founded
  • ADD 2002
  • APM 2010
  • Country
  • ADD United States
  • APM United Kingdom
  • Employees
  • ADD N/A
  • APM N/A
  • Industry
  • ADD Engineering & Construction
  • APM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADD Consumer Discretionary
  • APM Health Care
  • Exchange
  • ADD Nasdaq
  • APM Nasdaq
  • Market Cap
  • ADD 10.3M
  • APM 9.8M
  • IPO Year
  • ADD N/A
  • APM 2018
  • Fundamental
  • Price
  • ADD $5.90
  • APM $0.76
  • Analyst Decision
  • ADD
  • APM
  • Analyst Count
  • ADD 0
  • APM 0
  • Target Price
  • ADD N/A
  • APM N/A
  • AVG Volume (30 Days)
  • ADD 487.0K
  • APM 25.7K
  • Earning Date
  • ADD 11-23-2024
  • APM 12-20-2024
  • Dividend Yield
  • ADD N/A
  • APM N/A
  • EPS Growth
  • ADD N/A
  • APM N/A
  • EPS
  • ADD N/A
  • APM N/A
  • Revenue
  • ADD $2,830,442.00
  • APM $431,378.00
  • Revenue This Year
  • ADD N/A
  • APM $157,729.10
  • Revenue Next Year
  • ADD N/A
  • APM N/A
  • P/E Ratio
  • ADD N/A
  • APM N/A
  • Revenue Growth
  • ADD N/A
  • APM N/A
  • 52 Week Low
  • ADD $0.06
  • APM $1.09
  • 52 Week High
  • ADD $1.85
  • APM $17.49
  • Technical
  • Relative Strength Index (RSI)
  • ADD 95.49
  • APM 16.33
  • Support Level
  • ADD $0.06
  • APM $1.21
  • Resistance Level
  • ADD $0.17
  • APM $1.37
  • Average True Range (ATR)
  • ADD 0.07
  • APM 0.11
  • MACD
  • ADD 0.39
  • APM -0.02
  • Stochastic Oscillator
  • ADD 90.68
  • APM 1.33

About ADD Color Star Technology Co. Ltd.

Color Star Technology Co Ltd is an entertainment technology and education company providing online and offline music education. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.

About APM Aptorum Group Limited

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Share on Social Networks: